Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant neoplasm of prostate
|
1082 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.100 | 0.690 | 29 | 1999 | 2015 | |||||
Prostate carcinoma
|
1168 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.100 | 0.690 | 29 | 1999 | 2015 | |||||
Benign Prostatic Hyperplasia
|
91 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.080 | 0.875 | 8 | 2002 | 2017 | |||||
Hypospadias
|
80 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.050 | 1.000 | 5 | 2005 | 2017 | |||||
Penile hypospadias
|
83 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.050 | 1.000 | 5 | 2005 | 2017 | |||||
Breast Carcinoma
|
2793 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.040 | 0.500 | 4 | 2002 | 2015 | |||||
Malignant neoplasm of breast
|
3417 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.040 | 0.500 | 4 | 2002 | 2015 | |||||
Metabolic Syndrome X
|
591 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Micropenis
|
21 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.020 | 1.000 | 2 | 2003 | 2014 | |||||
Penis agenesis
|
11 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.020 | 1.000 | 2 | 2003 | 2014 | |||||
Polycystic Ovary Syndrome
|
363 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.020 | 1.000 | 2 | 2006 | 2011 | |||||
Alcoholic Intoxication, Chronic
|
441 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Liver carcinoma
|
942 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.010 | 1.000 | 1 | 2001 | 2001 | |||||
Maternal hypertension
|
22 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Metastasis from malignant tumor of prostate
|
18 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Metastatic Prostate Carcinoma
|
24 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Miscarriage
|
56 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Neoplasm Metastasis
|
327 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.010 | 1.000 | 1 | 2002 | 2002 | |||||
Neoplasms
|
1644 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.010 | 1.000 | 1 | 2000 | 2000 | |||||
Post-Traumatic Stress Disorder
|
117 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Secondary Neoplasm
|
85 | 0.689 | 0.440 | 2 | 31580636 | missense variant | G/A;C;T | snv | 0.66; 4.9E-06 | 0.010 | 1.000 | 1 | 2002 | 2002 |